Stay updated on Amivantamab Combo Therapy Clinical Trial
Sign up to get notified when there's something new on the Amivantamab Combo Therapy Clinical Trial page.

Latest updates to the Amivantamab Combo Therapy Clinical Trial page
- Check7 days agoChange DetectedAdded a new publication reference: PAPILLON Asia subgroup analysis in Lung Cancer (2026) with DOI 10.1016/j.lungcan.2026.109302.SummaryDifference0.0%

- Check14 days agoChange DetectedAdministrative site updates were applied, including Revision: v3.4.2 and new date stamps (2026-02-04, 2026-01-15, 2026-01). A site-wide government funding status notice banner was removed.SummaryDifference0.2%

- Check21 days agoChange DetectedA notice about a lapse in government funding and the NIH Clinical Center's status was added to the page. The page revision tag was updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check28 days agoChange DetectedAdded a glossary display and updated metadata fields (Last Update Submitted that Met QC Criteria, Last Update Posted, Revision: v3.4.0). Removed or renamed older labels (Last Update Submitted that met QC Criteria, Last Update Posted (Estimated), No FEAR Act data, Revision: v3.3.4).SummaryDifference0.1%

- Check42 days agoChange DetectedPage meta shows a new Revision: v3.3.4 replacing v3.3.3 in the Study Documents section; this is a minor metadata update and does not affect core content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check58 days agoChange DetectedAdministrative updates are visible on the page with new dates (e.g., 2025-12-23, 2025-12-04), and no changes were made to the study design, eligibility, outcomes, or primary content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Amivantamab Combo Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Amivantamab Combo Therapy Clinical Trial page.